LEF-1 regulates proliferation and MMP-7 transcription in breast cancer cells

Genes to Cells

Volumn 17, Issue 7, 2012, Pages 559-567

  Bucan, Vesna ^a   Mandel, Katharina ^a   Bertram, Catharina ^a   Lazaridis, Andrea ^a   Reimers, Kerstin ^a   Park Simon, Tjoung Won ^a   Vogt, Peter M ^a   Hass, Ralf ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; LYMPHOID ENHANCER FACTOR 1; MATRILYSIN; SMALL INTERFERING RNA;

ARTICLE; BIOINFORMATICS; BREAST CANCER; CANCER GROWTH; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GEL MOBILITY SHIFT ASSAY; GENE LOCUS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION;

BASE SEQUENCE; BINDING SITES; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPHOID ENHANCER-BINDING FACTOR 1; MATRIX METALLOPROTEINASE 7; PROMOTER REGIONS, GENETIC; RNA INTERFERENCE; TRANSCRIPTION, GENETIC;

EID: 84862761072     PISSN: 13569597     EISSN: 13652443     Source Type: Journal    
DOI: 10.1111/j.1365-2443.2012.01613.x     Document Type: Article

References (47)

1. Adachi, Y., Yamamoto, H., Itoh, F., Arimura, Y., Nishi, M., Endo, T. & Imai, K. (2001) Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancers. Int. J. Cancer 95, 290-294.
2. Ajisaka, H., Yonemura, Y. & Miwa, K. (2004) Correlation of lymph node metastases and expression of matrix metalloproteinase-7 in patients with gastric cancer. Hepatogastroenterology 51, 900-905.
3. Bertram, C. & Hass, R. (2008) MMP-7 is involved in the aging of primary human mammary epithelial cells (HMEC). Exp. Gerontol. 43(3), 209-217.
4. Bertram, C. & Hass, R. (2009) Cellular senescence of human mammary epithelial cells (HMEC) is associated with an altered MMP-7/HB-EGF signaling and increased formation of elastin-like structures. Mech. Ageing Dev. 30, 657-669.
5. Binder, C., Hagemann, T., Husen, B., Schulz, M. & Einspanier, A. (2002) Relaxin enhances in-vitro invasiveness of breast cancer cell lines by up-regulation of matrix metalloproteases. Mol. Hum. Reprod. 8, 789-796.
6. Birkedal-Hansen, B., Pavelic, Z.P., Gluckman, J.L., Stambrook, P., Li, Y.Q. & Stetler-Stevenson, W.G. (2000) MMP and TIMP gene expression in head and neck squamous cell carcinomas and adjacent tissues. Oral Dis. 6, 376-382.
7. Brábek, J., Mierke, C.T., Rösel, D., Veselý, P. & Fabry, B. (2010) The role of the tissue microenvironment in the regulation of cancer cell motility and invasion. Cell Commun. Signal. 8, 22.
8. Brabletz, T., Jung, A., Dag, S., Hlubek, F. & Kirchner, T. (1999) Beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer. Am. J. Pathol. 155(4), 1033-1038.
9. Brabletz, T., Jung, A., Reu, S., Porzner, M., Hlubek, F., Kunz-Schughart, L.A., Knuechel, R. & Kirchner, T. (2001) Variable beta-catenin expression in colorectal cancers indicates tumor progression driven by the tumor environment. Proc. Natl Acad. Sci. USA 98, 10356-10361.
10. Bucan, V., Reimers, K., Choi, C.Y., Eddy, M.T. & Vogt, P.M. (2010) The anti-apoptotic protein lifeguard is expressed in breast cancer cells and tissues. Cell. Mol. Biol. Lett. 15, 296-310.
11. Calorini, L. & Bianchini, F. (2010) Environmental control of invasiveness and metastatic dissemination of tumor cells: the role of tumor cell-host cell interactions. Cell Commun. Signal. 8, 24.
12. Chaturvedi, S. & Hass, R. (2011) Extracellular signals in young and aging breast epithelial cells and possible connections to age-associated breast cancer development. Mech. Ageing Dev. 132, 213-219.
13. Chung, G.G., Zerkowski, M.P., Ocal, I.T., Dolled-Filhart, M., Kang, J.Y., Psyrri, A., Camp, R.L. & Rimm, D.L. (2004) beta-Catenin and p53 analyses of a breast carcinoma tissue microarray. Cancer 100, 2084-2092.
14. Hagemann, T., Robinson, S.C., Schulz, M., Trumper, L., Balkwill, F.R. & Binder, C. (2004) Enhanced invasiveness of breast cancer cell lines upon co-cultivation with macrophages is due to TNF-alpha dependent up-regulation of matrix metalloproteases. Carcinogenesis 25, 1543-1549.
15. Hasegawa, S., Koshikawa, N., Momiyama, N., Moriyama, K., Ichikawa, Y., Ishikawa, T., Mitsuhashi, M., Shimada, H. & Miyazaki, K. (1998) Matrilysin-specific antisense oligonucleotide inhibits liver metastasis of human colon cancer cells in a nude mouse model. Int. J. Cancer 76, 812-816.
16. Hashimoto, K., Kihira, Y., Matuo, Y. & Usui, T. (1998) Expression of matrix metalloproteinase-7 and tissue inhibitor of metalloproteinase-1 in human prostate. J. Urol. 160, 1872-1876.
17. Hass, R. & Bertram, C. (2009) Characterization of human breast cancer epithelial cells (HBCEC) derived from long term cultured biopsies. J. Exp. Clin. Cancer Res. 28, 127.
18. Hass, R., Kasper, C., Böhm, S. & Jacobs, R. (2011) Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun. Signal. 9, 12.
19. Hovanes, K., Li, T.W. & Waterman, M.L. (2000) The human LEF-1 gene contains a promoter preferentially active in lymphocytes and encodes multiple isoforms derived from alternative splicing. Nucleic Acids Res. 28, 1994-2003.
20. Howe, D. & Bromidge, T. (2006) Variation of LEF-1 mRNA expression in low-grade B-cell non-Hodgkin's lymphoma. Leuk. Res. 3, 29-32.
21. Jones, L.E., Humphreys, M.J., Campbell, F., Neoptolemos, J.P. & Boyd, M.T. (2004) Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 predicts poor survival. Clin. Cancer Res. 10, 2832-2845.
22. Kan, J.S., Delassus, G.S., D'Souza, K.G., Hoang, S., Aurora, R. & Eliceiri, G.L. (2002) Modulators of cancer cell invasiveness. J. Cell. Biochem. 111, 791-796.
23. Kitoh, T., Yanai, H., Saitoh, Y., Nakamura, Y., Matsubara, Y., Kitoh, H., Yoshida, T. & Okita, K. (2004) Increased expression of matrix metalloproteinase-7 in invasive early gastric cancer. J. Gastroenterol. 39, 434-440.
24. Lavrentieva, A., Majore, I., Kasper, C. & Hass, R. (2010) Effects of hypoxic culture conditions on umbilical cord-derived human mesenchymal stem cells. Cell Commun. Signal. 8, 18.
25. Li, F.Q., Person, R.E., Takemaru, K., Williams, K., Meade-White, K., Ozsahin, A.H., Gungor, T., Moon, R.T. & Horwitz, M. (2004) Lymphoid enhancer factor-1 links two hereditary leukemia syndromes through core-binding factor alpha regulation of ELA2. J. Biol. Chem. 279, 2873-2884.
26. Majore, I., Moretti, P., Hass, R. & Kasper, C. (2009) Identification of subpopulations in mesenchymal stem cell-like cultures from human umbilical cord. Cell Commun. Signal. 7(1), 6.
27. Maurel, J., Nadal, C., Garcia-Albeniz, X., Gallego, R., Carcereny, E., Almendro, V., Mármol, M., Gallardo, E., Maria Augé, J., Longarón, R., Martínez-Fernandez, A., Molina, R., Castells, A. & Gascón, P. (2007) Serum matrix metalloproteinase 7 levels identifies poor prognosis advanced colorectal cancer patients. Int. J. Cancer 121, 1066-1071.
28. Miyata, Y., Iwata, T., Ohba, K., Kanda, K., Nishikido, M. & Kanetake, H. (2006) Expression of matrix metalloproteinase-7 on cancer cells and tissue endothelial cells in renal cell carcinoma: prognostic implications and clinical significance for invasion and metastasis. Clin. Cancer Res. 12, 6998-7003.
29. Nguyen, A., Rosner, A., Milovanovic, T., Hope, C., Planutis, K., Saha, B., Chaiwun, B., Lin, F., Imam, S.A., Marsh, J.L. & Holcombe, R.F. (2005) Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression. Int. J. Oncol. 27, 949-956.
30. Ohashi, K., Nemoto, T., Nakamura, K. & Nemori, R. (2000) Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1-matrix metalloproteinase in esophageal squamous cell carcinomas. Cancer 88, 2201-2209.
31. Okamoto, I., Tsuiki, H., Kenyon, L.C., Godwin, A.K., Emlet, D.R., Holgado-Madruga, M., Lanham, I.S., Joynes, C.J., Vo, K.T., Guha, A., Matsumoto, M., Ushio, Y., Saya, H. & Wong, A.J. (2002) Proteolytic cleavage of the CD44 adhesion molecule in multiple human tumors. Am. J. Pathol. 160, 441-447.
32. Ovcharenko, I., Nobrega, M.A., Loots, G.G. & Stubbs, L. (2004) ECR Browser: a tool for visualizing and accessing data from comparisons of multiple vertebrate genomes. Nucleic Acids Res. 32, W280-W286.
33. Overall, C.M. & Lopez-Otin, C. (2002) Strategies for MMP inhibition in cancer: innovations for the post-trial era. Nat. Rev. Cancer 2, 657-672.
34. Pacheco, M.M., Mourao, M., Mantovani, E.B., Nishimoto, I.N. & Brentani, M.M. (1998) Expression of gelatinases A and B, stromelysin-3 and matrilysin genes in breast carcinomas: clinicopathological correlations. Clin. Exp. Metastasis 16, 577-585.
35. Ramankulov, A., Lein, M., Johannsen, M., Schrader, M., Miller, K. & Jung, K. (2008) Plasma matrix metalloproteinase-7 as a metastatic marker and survival predictor in patients with renal cell carcinomas. Cancer Sci. 99, 1188-1194.
36. Rubinfeld, B., Robbins, P., El-Gamil, M., Albert, I., Porfiri, E. & Polakis, P. (1997) Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science 275, 1790-1792.
37. Sasaki, H., Yukiue, H., Moiriyama, S., Kobayashi, Y., Nakashima, Y., Kaji, M., Kiriyama, M., Fukai, I., Yamakawa, Y. & Fujii, Y. (2001) Clinical significance of matrix metalloproteinase-7 and Ets-1 gene expression in patients with lung cancer. J. Surg. Res. 101, 242-247.
38. Shiomi, T. & Okada, Y. (2003) MT1-MMP and MMP-7 in invasion and metastasis of human cancers. Cancer Metastasis Rev. 22, 145-152.
39. Simon, M., Grandage, V.L., Linch, D.C. & Khwaja, A. (2005) Constitutive activation of the Wnt/beta-catenin signalling pathway in acute myeloid leukaemia. Oncogene 24, 2410-2420.
40. Tanimoto, H., Underwood, L.J., Shigemasa, K., Parmley, T.H., Wang, Y., Yan, Y., Clarke, J. & O'Brien, T.J. (1999) The matrix metalloprotease pump-1 (MMP-7, Matrilysin): a candidate marker/target for ovarian cancer detection and treatment. Tumour Biol. 20, 88-98.
41. Vehement, P. & Kahari, V.M. (2002) Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. Int. J. Cancer 99, 157-166.
42. Wang, F., Reierstad, S. & Fishmann, D.A. (2006) Matrilysin over-expression in MCF-7 cells enhances cellular invasiveness and pro-gelatinase activation. Cancer Lett. 236(2), 292-301.
43. Waterman, M.L. (2004) Lymphoid enhancer factor/T cell factor expression in colorectal cancer. Cancer Metastasis Rev. 23, 41-52.
44. Welte, Y., Adjaye, J., Lehrach, H.R. & Regenbrecht, C.R. (2010) Cancer stem cells in solid tumors: elusive or illusive? Cell Commun. Signal. 8, 6.
45. Yamamoto, H., Adachi, Y., Itoh, F., Iku, S., Matsuno, K., Kusano, M., Arimura, Y., Endo, T., Hinoda, Y., Hosokawa, M. & Imai, K. (1999) Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma. Cancer Res. 59, 3313-3316.
46. Yamamoto, H., Iku, S., Adachi, Y., Imsumran, A., Taniguchi, H., Nosho, K., Min, Y., Horiuchi, S., Yoshida, M., Itoh, F. & Imai, K. (2003) Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancer. J. Pathol. 199, 176-184.
47. Zeng, Z.S., Shu, W.P., Cohen, A.M. & Guillem, J.G. (2002) Matrix metalloproteinase-7 expression in colorectal cancer liver metastases: evidence for involvement of MMP-7 activation in human cancer metastases. Clin. Cancer Res. 8, 144-148.